Search

Syntheses of 4-O-methyl-β-rhodomycins are described. Glycosylation (trimethylsilyl triflate, dichloromethane-acetone 10:1, -30 °C) of 4-O-methyl-10-O-p-nitrobenzoyl-β-rhodomycinone, obtained from β-rhodomycinone (βRMN) in a 6-step synthesis, with 1-O-tert-butyl(dimethyl)silylated derivatives of 4-O-acetyl- or 4-O-p-nitrobenzoyl-2,3,6-tri-deoxy-3-trifluoroacetylamino-β-L-arabino- and lyxo-hexopyranoses or 2,6-di-O-acetyl-2,6-dideoxy-β-L-lyxo-hexopyranose afforded 7-O-α-L-glycosyl-β-rhodomycinones. Removal of the O- and N-acyl groups with 0.1M and 1M NaOH gave the 7-O-(3-amino-2,3,6-trideoxy-α-L-arabino- and lyxo-hexopyranosyl)-4-O-methyl-β-rhodomycinones and 7-O-(2,6-dideoxy-α-L-lyxo-hexopyranosyl)-4-O-methyl-β-rhodomycinone.

It was found that rhodosaminylanthraclinone-type anthracyclines are readily N-mono-demethylated upon irradiation with visible light, leading to 3′-N-methyl-α-L-daunosarninylanthracyclinones in good yields. The reaction is preferentially observed with rhodosaminylanthracyclinones in which OH-4′ of the sugar (rhodosamine) moiety is not further glycosylated. 3′-N-methyl-α-L-daunosaminyl anthracyclinones provide key compounds that can readily be further derivatized.

The synthesis of 7-O-α-L-daunosaminyl-4-O-methyl-β-rhodomycinone (3) and the determination of its cytotoxic potency compared to that of the natural 7-O-α-L-dau-nosaminyl-β-rhodomycinone (4) are described. Starting with natural β-rhodomycinone (7), trimethylsilyl protecting groups were attached to the hydroxy groups at position 7 and 10, and the 4-OH group was subsequently methylated (MeI/Cs2CO3), thus providing the 4-O-methyl-7, 10-bis-O-trimethylsilyl-β-rhodomycinone (10). The two TMS groups were then deblocked to give 4-O-methyl-β-rhodomycinone (12). In a 3-stage synthesis 12 was converted into 4-O-methyl-10-O-trifiuoroacetyl-s-rhodomycinone (15) to which l, 4-bis-O-p-nitrobenzoyl-3-N-trifluoroacetyl-L-daunosamine 16 was selectively linked to afford the 7-O-α-glycoside 17. The acyl protective groups are removed by treatment with 1N NaOH to give 3.

The synthesis of the glycosyl donors 2,3-di-O-acetyl- and 2,3-di-O-chloroacetyl- 4,6-O-ethylidene-s-D-glucopyranose (10β) and (11β) and their use for the glycosidation of 4'-O-benzyloxycarbonyl- and 4'-O-chloroacetyl-4'-O-demethyl-4-epi-podophyllotoxins (12) and (13) is described. Starting from benzyl β-D-glucopyranoside (6), benzyl 2,3-di-O-acetyl- and 2,3-di-O-chloroacetyl-4,6-O-ethylidene-s-D-glucopyranoside (8) and (9) were prepared. Hydrogenolysis of the benzyl group in 8 or 9 afforded the β-hydroxy glucopyranose donors 10β and 11β. Condensation of 10β or 11β with 4'-O-Z-epi-podophyllotoxin 12 in the presence of BF3-etherate gave selectively the 4-O-(2,3-di-O-acetyl- or -2,3-di-O-chloroacetyl-4,6-O-ethylidene-β-D-glucopyranosyl)-epi-podophyllotoxins 14β and 15β, respectively. The β-glycoside 16 was prepared in the same manner starting from 11β and 4'-O-chloroacetyl-epi-podophyllotoxin 13. By deblocking (Dowex 1X8, 3:2 methanol-chloroform) of the chloroacetyl groups in 15β and the following h...

It was determined that β-rhodomycin-II (rhodomycin A) (1), β-rhodomycin-I (rhodomycin B, betaclamycin T) (2) and γ-rhodomycin-I (iremycin) (3) may regioselectively be acylated at OH-4′ of the sugar (rhodosamine) moiety(ies), using a two-phase (chloroform/water) solvent system and sodium bicarbonate as a base. This report exemplarily describes the synthesis of the corresponding p-methoxybenzoate esters of 1, 2, and 3, i. e. derivatives 4–7, and highlights the structure elucidation of isomers 5a and 5b.

10-O-(R/S)Tetrahydropyranosyl-β-rhodomycinone (5a,b) was prepared via 7,9-O-phenylboronyl-β-rhodomycinone (3) from β-rhodomycinone (1). Glycosidation of 5a,b with 3,4-di-O-acetyl-1,5-anhydro-2,6-dideoxy-L-arabino-hex-1-enitol (3,4-di-O-acetyl-L-rhamnal) (6) and 3,4-di-O-acetyl-1,5-anhydro-2,6-dideoxy-L-lyxo-hex-1-enitol (3,4-di-O-acetyl-L-fucal) (7) using N-iodosuccinimide gave the corresponding 7-O-glycosyl-β-rhodomycinones 8a,b, 9a,b and 10a,b, 11a,b. After cleavage of the THP-ether and O-deacetylation 7-O-(2,6-dideoxy-2-iodo-α-L-manno-hexopyranosyl)-β-rhodomycinone (14) and 7-O-(2,6-dideoxy-2-iodo-α-L-talo-hexopyranosyl)-β-rhodomycinone (16) were obtained.

The syntheses of 7-O-α-L-daunosaminyl-∊-isorhodomycinone (6) and 7-O-α-L-rhodosaminyl-∊-isorhodomycinone (7) are described. The glycosyl donors 1,4-di-O-p-nitrobenzoyl-3-N-trifluoroacetyl-α,β-L-daunosamine and 1,4-di-O-acetyl-α,β-L-rhodosamine have proven to be the most suitable for the glycosylation of ∊-isorhodomycinone (∊-iso RMN) (3), using the TMS triflate method. Deblocking (0.5 N NaOH) of the protected glycoside 4 led to the desired 7-O-glycosyl-∊-isorhodomycinones 5 and 6. The daunosaminyl glycoside 6 was methylated (CH2O, NaCNBH3) to provide the rhodosaminyl derivative 7. The photolytic demethylation of this product selectively provided the 7-O-(3′-N-methyl-α-L-daunosaminyl)-∊-isorhodomycinone (8).